Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/38519
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | FONSECA, Leonardo G. da | |
dc.contributor.author | REIG, Maria | |
dc.contributor.author | BRUIX, Jordi | |
dc.date.accessioned | 2020-12-16T14:57:19Z | - |
dc.date.available | 2020-12-16T14:57:19Z | - |
dc.date.issued | 2020 | |
dc.identifier.citation | CLINICS IN LIVER DISEASE, v.24, n.4, p.719-737, 2020 | |
dc.identifier.issn | 1089-3261 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/38519 | - |
dc.language.iso | eng | |
dc.publisher | W B SAUNDERS CO-ELSEVIER INC | eng |
dc.relation.ispartof | Clinics in Liver Disease | |
dc.rights | restrictedAccess | eng |
dc.subject | Hepatocellular carcinoma | eng |
dc.subject | Tyrosine kinase | eng |
dc.subject | Systemic treatment | eng |
dc.subject | Sorafenib | eng |
dc.subject | Lenvatinib | eng |
dc.subject | Cabozantinib | eng |
dc.subject | Regorafenib | eng |
dc.subject.other | endothelial growth-factor | eng |
dc.subject.other | phase-iii | eng |
dc.subject.other | protein-kinase | eng |
dc.subject.other | double-blind | eng |
dc.subject.other | treatment efficacy | eng |
dc.subject.other | 1st-line therapy | eng |
dc.subject.other | plus erlotinib | eng |
dc.subject.other | sorafenib | eng |
dc.subject.other | cancer | eng |
dc.subject.other | survival | eng |
dc.title | Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma | eng |
dc.type | article | eng |
dc.rights.holder | Copyright W B SAUNDERS CO-ELSEVIER INC | eng |
dc.identifier.doi | 10.1016/j.cld.2020.07.012 | |
dc.identifier.pmid | 33012455 | |
dc.subject.wos | Gastroenterology & Hepatology | eng |
dc.type.category | review | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.author.external | REIG, Maria:Hosp Clin Barcelona, Liver Unit, Barcelona Clin Liver Canc BCLC Grp, IDIBAPS, Villarroel 170, Barcelona 08036, Spain; Univ Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain | |
hcfmusp.author.external | BRUIX, Jordi:Hosp Clin Barcelona, Liver Unit, Barcelona Clin Liver Canc BCLC Grp, IDIBAPS, Villarroel 170, Barcelona 08036, Spain; Univ Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain | |
hcfmusp.description.beginpage | 719 | |
hcfmusp.description.endpage | 737 | |
hcfmusp.description.issue | 4 | |
hcfmusp.description.volume | 24 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.id | WOS:000582503300012 | |
hcfmusp.origem.id | 2-s2.0-85090305482 | |
hcfmusp.publisher.city | PHILADELPHIA | eng |
hcfmusp.publisher.country | USA | eng |
hcfmusp.relation.reference | Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441 | eng |
hcfmusp.relation.reference | Abou-Alfa GK, 2019, JAMA ONCOL, V5, P1582, DOI 10.1001/jamaoncol.2019.2792 | eng |
hcfmusp.relation.reference | Abou-Alfa GK, 2010, JAMA-J AM MED ASSOC, V304, P2154, DOI 10.1001/jama.2010.1672 | eng |
hcfmusp.relation.reference | Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145 | eng |
hcfmusp.relation.reference | Bosch J, 2010, J HEPATOL, V53, P558, DOI 10.1016/j.jhep.2010.03.021 | eng |
hcfmusp.relation.reference | Bruix J, 2019, NAT REV GASTRO HEPAT, V16, P617, DOI 10.1038/s41575-019-0179-x | eng |
hcfmusp.relation.reference | Bruix J, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.4_suppl.412 | eng |
hcfmusp.relation.reference | Bruix J, 2017, J HEPATOL, V67, P999, DOI 10.1016/j.jhep.2017.06.026 | eng |
hcfmusp.relation.reference | Bruix J, 2017, J HEPATOL, V66, P1114, DOI 10.1016/j.jhep.2017.02.032 | eng |
hcfmusp.relation.reference | Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9 | eng |
hcfmusp.relation.reference | Cainap C, 2015, J CLIN ONCOL, V33, P172, DOI 10.1200/JCO.2013.54.3298 | eng |
hcfmusp.relation.reference | Chao Y, 2003, ANN SURG ONCOL, V10, P355, DOI 10.1245/ASO.2003.10.002 | eng |
hcfmusp.relation.reference | Chen SZ, 2019, CANCER LETT, V460, P1, DOI 10.1016/j.canlet.2019.114428 | eng |
hcfmusp.relation.reference | Cheng AL, 2013, J CLIN ONCOL, V31, P4067, DOI 10.1200/JCO.2012.45.8372 | eng |
hcfmusp.relation.reference | Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7 | eng |
hcfmusp.relation.reference | COLLETT MS, 1978, P NATL ACAD SCI USA, V75, P2021, DOI 10.1073/pnas.75.4.2021 | eng |
hcfmusp.relation.reference | COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548 | eng |
hcfmusp.relation.reference | Diaz-Gonzalez A, 2019, ALIMENT PHARM THER, V49, P482, DOI 10.1111/apt.15088 | eng |
hcfmusp.relation.reference | European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019 | eng |
hcfmusp.relation.reference | Finn RS, 2020, NEW ENGL J MED, V382, P1894, DOI 10.1056/NEJMoa1915745 | eng |
hcfmusp.relation.reference | Firtina K. Z., 2016, CANCER SCI, V107, P407, DOI 10.1111/cas.12891 | eng |
hcfmusp.relation.reference | Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256 | eng |
hcfmusp.relation.reference | Hage C, 2019, HEPATOLOGY, V70, P1280, DOI 10.1002/hep.30666 | eng |
hcfmusp.relation.reference | Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013 | eng |
hcfmusp.relation.reference | HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032 | eng |
hcfmusp.relation.reference | Hopkin MD, 2010, CHEM COMMUN, V46, P2450, DOI 10.1039/c001550d | eng |
hcfmusp.relation.reference | Hu G, 2018, ONCOL LETT, V16, P3439, DOI 10.3892/ol.2018.9078 | eng |
hcfmusp.relation.reference | Huynh H, 2003, BMC GASTROENTEROL, V19, P1 | eng |
hcfmusp.relation.reference | Ikeda K, 2017, J GASTROENTEROL, V52, P512, DOI 10.1007/s00535-016-1263-4 | eng |
hcfmusp.relation.reference | Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410 | eng |
hcfmusp.relation.reference | Kaseb AO, 2012, ONCOLOGY-BASEL, V82, P67, DOI 10.1159/000335963 | eng |
hcfmusp.relation.reference | Kato Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212513 | eng |
hcfmusp.relation.reference | Kittler H, 2018, BRIT J DERMATOL, V178, P26, DOI 10.1111/bjd.16119 | eng |
hcfmusp.relation.reference | Kudo M, 2020, GUT, V69, P1492, DOI 10.1136/gutjnl-2019-318934 | eng |
hcfmusp.relation.reference | Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1 | eng |
hcfmusp.relation.reference | Kudo M, 2014, HEPATOLOGY, V60, P1697, DOI 10.1002/hep.27290 | eng |
hcfmusp.relation.reference | Lencioni R, 2016, J HEPATOL, V64, P1090, DOI 10.1016/j.jhep.2016.01.012 | eng |
hcfmusp.relation.reference | Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132 | eng |
hcfmusp.relation.reference | LLOVET JM, 2019, J CLIN ONCOL S, V37 | eng |
hcfmusp.relation.reference | Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857 | eng |
hcfmusp.relation.reference | Llovet JM, 2013, J CLIN ONCOL, V31, P3509, DOI 10.1200/JCO.2012.47.3009 | eng |
hcfmusp.relation.reference | Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175 | eng |
hcfmusp.relation.reference | Marrero JA, 2016, J HEPATOL, V65, P1140, DOI 10.1016/j.jhep.2016.07.020 | eng |
hcfmusp.relation.reference | Maurer G, 2011, ONCOGENE, V30, P3477, DOI 10.1038/onc.2011.160 | eng |
hcfmusp.relation.reference | Medical Advisory Secretariat, 2010, Ont Health Technol Assess Ser, V10, P1 | eng |
hcfmusp.relation.reference | Mohanlal RW, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.7_suppl.139 | eng |
hcfmusp.relation.reference | Morgan RL, 2018, J THORAC ONCOL, V13, P154, DOI 10.1016/j.jtho.2017.10.015 | eng |
hcfmusp.relation.reference | Motzer RJ, 2006, EXPERT OPIN INV DRUG, V15, P553, DOI 10.1517/13543784.15.5.553 | eng |
hcfmusp.relation.reference | Park JW, 2019, J HEPATOL, V70, P684, DOI 10.1016/j.jhep.2018.11.029 | eng |
hcfmusp.relation.reference | Paschalis G, 2013, SURG CHRONICLES, V18, P134 | eng |
hcfmusp.relation.reference | Rankin EB, 2016, CANCERS, V8, DOI 10.3390/cancers8110103 | eng |
hcfmusp.relation.reference | Reig M, 2014, J HEPATOL, V61, P318, DOI 10.1016/j.jhep.2014.03.030 | eng |
hcfmusp.relation.reference | Reig M, 2013, HEPATOLOGY, V58, P2023, DOI 10.1002/hep.26586 | eng |
hcfmusp.relation.reference | Ricke J, 2018, J HEPATOL, V68, pS102, DOI 10.1016/S0168-8278(18)30424-0 | eng |
hcfmusp.relation.reference | Rimassa L, 2018, LANCET ONCOL, V19, P682, DOI 10.1016/S1470-2045(18)30146-3 | eng |
hcfmusp.relation.reference | Rimola J, 2018, HEPATOLOGY, V67, P612, DOI 10.1002/hep.29515 | eng |
hcfmusp.relation.reference | Shao YY, 2010, CANCER-AM CANCER SOC, V116, P4590, DOI 10.1002/cncr.25257 | eng |
hcfmusp.relation.reference | Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124 | eng |
hcfmusp.relation.reference | Tai WT, 2012, MOL CANCER THER, V11, P452, DOI 10.1158/1535-7163.MCT-11-0412 | eng |
hcfmusp.relation.reference | THOMAS MB, 2015, J CLIN ONCOL S, V33 | eng |
hcfmusp.relation.reference | Vennepureddy A, 2017, J ONCOL PHARM PRACT, V23, P525, DOI 10.1177/1078155216655474 | eng |
hcfmusp.relation.reference | Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263 | eng |
hcfmusp.relation.reference | Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008 | eng |
hcfmusp.relation.reference | Voron T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00070 | eng |
hcfmusp.relation.reference | Wang B, 2008, ACTA RADIOL, V49, P523, DOI 10.1080/02841850801958890 | eng |
hcfmusp.relation.reference | Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864 | eng |
hcfmusp.relation.reference | Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443 | eng |
hcfmusp.relation.reference | Zhao XX, 2016, INNATE IMMUN-LONDON, V22, P493, DOI 10.1177/1753425916659702 | eng |
hcfmusp.relation.reference | Zhu AX, 2019, LANCET ONCOL, V20, P282, DOI 10.1016/S1470-2045(18)30937-9 | eng |
hcfmusp.relation.reference | Zhu AX, 2015, LANCET ONCOL, V16, P859, DOI 10.1016/S1470-2045(15)00050-9 | eng |
hcfmusp.relation.reference | Zhu AX, 2015, J CLIN ONCOL, V33, P559, DOI 10.1200/JCO.2013.53.7746 | eng |
hcfmusp.relation.reference | Zocco MA, 2013, J HEPATOL, V59, P1014, DOI 10.1016/j.jhep.2013.06.011 | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.eissn | 1557-8224 | |
hcfmusp.citation.scopus | 12 | - |
hcfmusp.scopus.lastupdate | 2022-04-28 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - HC/ICESP Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_FONSECA_Tyrosine_Kinase_Inhibitors_and_Hepatocellular_Carcinoma_2020.PDF.pdf Restricted Access | publishedVersion (English) | 894.29 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.